Lead, Pricing & Planning Americas Market Access, Global Rare Diseases

Select how often (in days) to receive an alert:

Date:
Jul 20, 2026

Job Type: Direct Employee

Business Area:
Mktg, Market Access, Bus. Excellence & Med. Affair

Contract Type:
Permanent

Location:

Boston, MA, US

About Us

Based in Parma, Italy, Chiesi is an international research-focused biopharmaceutical group with 90 years’ experience, operating in 31 countries. More than 8,000 employees across the group are united by a singular purpose: promoting a healthier world for our people, patients, and the planet. This is what drives us as we research, develop, and market innovative drugs across our main therapeutic areas.

Discover more here.

At Chiesi we are thinking generations ahead, driving sustainable innovation with purpose. This fosters a culture of reliability, transparency, and ethical behaviour at every level. As a Benefit Corporation and a certified B Corp, we have embedded sustainability in our bylaws and continuously measure our impact.

Diversity, inclusion, and equal opportunity are at the heart of who we are. We believe our differences make us stronger. We are a vibrant ecosystem of passionate, talented individuals united by strong values, each bringing unique perspectives that help us to continuously challenge the status quo for the better.

Chiesi Global Rare Diseases

Chiesi Global Rare Diseases is a Chiesi Group’s business unit established in February 2020 and focused on research, development and commercialization of treatments and patient support services for rare and ultra-rare disorders, many of whom have limited or no treatments available.

This unit is based in Boston, Massachusetts, with a strong synergy with the headquarters in Parma.

Rare unit has a focus on research and product development for lysosomal storage diseases, rare hematology, ophthalmology disorders and rare immunodeficiencies. The unit is also a dedicated partner with global leaders in scientific research, patient advocacy and care. Discover more here.

The Lead, Pricing & Planning, Global Rare Diseases will serve as the Market Access strategic partner for the Rare Disease portfolio, ensuring that payer, contracting, and reimbursement insights are effectively integrated into business cases, pricing strategies, and commercialization plans for the full Chiesi GRD portfolio (8-10 reimbursed products). This role focuses on shaping GTN‑relevant assumptions and interpreting GTN outputs in close collaboration with FP&A and Government Pricing.

This high impact role will also be responsible for the development and implementation of strategic, cross-functional business cases, ensuring alignment with global commercialization strategies for the full Chiesi GRD portfolio (8-10 reimbursed products).

Reporting to the Headof Contracting,Forecasting,Pricing,Americas Market Access ,Global Rare Diseases , this role provides subject‑matter expertise on contracting strategy, reimbursement trends, and marketplace shifts that influence GTN outcomes. The Lead will translate these insights into strategic recommendations, scenario inputs, and cross‑functional business cases aligned with global commercialization strategies for the Chiesi GRD portfolio. They will also partner closely with FP&A to embed these recommendations into budget cycles, forecasts, and long‑range planning models.,

GRD scenario planning, and GRD forecasting in partnership with FP&A, Market Access, Patient Services and Government Pricing. You will undertake various modelling and scenario planning analyses to drive financial accuracy in alignment with FP&A cycles for budgeting and forecasting. This role is critical to integrating the dynamics of the marketplace and government policies into financial performance.

As a leader within the Market Access team, you will also assist in building Market Access related business cases related to the optimization of our discounting strategy through the formulation of insights and assumptions for the GRD portfolio. This will require an extensive knowledge of Chiesi’s HUB services, trade & distribution strategy, and the reimbursement landscape for various…